首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1451216

2024-2032 年按技術（射頻消融、微波消融、冷凍消融等）、治療模式、應用模式、最終用戶和地區分類的腫瘤消融市場報告

Tumor Ablation Market Report by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment, Mode of Application, End-User, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球腫瘤消融市場規模達12億美元。展望未來， IMARC Group預計到2032年市場規模將達到31億美元，2024-2032年複合年成長率（CAGR）為10.8%。全球癌症發生率不斷上升、醫療技術不斷進步以及大眾對微創癌症治療的認知不斷增強，這些都是推動市場發展的一些因素。

腫瘤消融是一種醫療程序，涉及移除或破壞異常組織，特別是癌性腫瘤，而不需要手術切除。這種微創方法採用射頻、雷射、微波或冷凍消融等多種技術，瞄準癌細胞並精確根除它們。該過程的特點是能夠最大限度地減少對周圍健康組織的損害，從而縮短恢復時間並提高患者的生活品質。這些治療通常由超音波、CT 掃描或 MRI 等影像技術引導，這些技術可提供即時資料以提高準確性。

全球腫瘤消融市場主要是由全球癌症發生率不斷上升所推動的。與此相一致，醫療技術的不斷進步正在為市場提供動力。此外，大眾對微創癌症治療的認知不斷增強，是市場成長的重要推手。除此之外，更容易罹患癌症的老化人口導致對腫瘤消融療法的投資增加。除此之外，醫療保健系統對減少手術併發症的關注正在為市場創造利潤豐厚的機會。此外，精準醫療的出現正在對市場產生正面影響。醫療保健支出的增加進一步推動了市場，特別是在已開發國家。對該市場做出貢獻的其他一些因素包括醫療旅遊業的興起、先進醫療設施的普及以及廣泛的研發（R&D）活動。

腫瘤消融市場趨勢/促進因素：

以病人為中心的方法的興起

現代醫療保健格局越來越注重個人化護理，根據每位患者的獨特需求和情況量身定做治療方案。這種以患者為中心的轉變改變了腫瘤消融市場的遊戲規則。透過設計考慮各種患者因素（例如年齡、病史和遺傳傾向）的療法，醫療保健提供者正在製定高度針對性和有效的治療計劃。這種個人化方法對於癌症患者尤其重要，由於腫瘤的異質性，他們通常有獨特的治療反應。透過利用資料分析、基因組學和個人化病史，醫療保健提供者能夠更好地為個別患者選擇最合適的腫瘤消融治療。這種更高程度的個人化不僅提高了治療效果，還提高了患者的滿意度和信任度，從而鼓勵更多的人選擇腫瘤消融治療。

數位科技的不斷融合

將人工智慧（AI）、機器學習和巨量資料分析等數位技術融入醫療保健系統是市場擴張的驅動力。這些技術使醫療保健提供者能夠根據全面的資料分析（包括患者病史、即時監測和預測建模）做出更明智的決策。這些數位化進步不僅限於患者診斷和治療計劃。它們也擴展到醫療保健系統的營運方面，簡化管理，降低管理成本，並提高提供護理的效率。數位技術有助於不同部門甚至不同醫療機構之間即時共享訊息，從而更容易協調患者護理並根據需要調整治療。營運效率的提高不僅改善了患者的治療效果，而且使腫瘤消融療法的採用對於醫療保健系統來說在經濟上更加可行。

主要參與者之間的合作夥伴關係和收購不斷增加

來自公共和私營部門的投資湧入在塑造市場方面發揮關鍵作用。政府補助、補貼和公共資金是醫療保健領域研究和發展的基礎支持。這些資金使醫學研究人員能夠探索腫瘤消融的創新技術和技術，而無需面臨市場生存的直接壓力。另一方面，私人投資（通常以創投的形式）加速了這些新技術的商業化。公共和私人金融利益的結合往往可以帶來突破性的創新，因為它將學術嚴謹性和以市場為導向的方法結合在一起。例如，公共資金可以支持開發新型腫瘤消融技術所需的早期研究，而私人投資可以促進將其推向市場所需的臨床試驗和行銷。這種雙重投資流不僅加快了創新步伐，而且創造了更強勁和充滿活力的市場格局，培養競爭力，從而推動市場成長。

市場結構
關鍵參與者
關鍵參與者簡介
- Medtronic Public Limited Company
- AngioDynamics Inc.
- HealthTronics Inc.
- NeuWave Medical, Inc.
- INTIO Inc.
- Galil Medical Ltd
- Boston Scientific Corporation
- SonaCare Medical LLC
- EDAP TMS SA
- Erbe Elektromedizin GmbH
- IceCure Medical Ltd
- MISONIX Inc.
- Endocare Inc.
- CooperSurgical Inc.
- BVM Meditech Pvt

簡介目錄圖表

Product Code: SR112024A1629

The global tumor ablation market size reached US$ 1,200 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,100 Million by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032. The increasing incidence of cancer cases across the globe, continual advancements in medical technology, and growing awareness about minimally invasive cancer treatments among the masses represent some of the factors that are propelling the market.

Tumor ablation is a medical procedure that involves the removal or destruction of abnormal tissue, particularly cancerous tumors, without the need for surgical excision. Employing various techniques such as radiofrequency, laser, microwave, or cryoablation, this minimally invasive approach targets cancerous cells and eradicates them with precision. The process is characterized by its ability to minimize damage to surrounding healthy tissues, thereby reducing recovery time and improving the patient's quality of life. These treatments are typically guided by imaging technologies such as ultrasound, CT scans, or MRI, which provide real-time data for higher accuracy.

The global market for tumor ablation is primarily driven by the increasing incidence of cancer cases across the globe. In line with this, continual advancements in medical technology are providing an impetus to the market. Moreover, the growing awareness about minimally invasive cancer treatments among the masses is acting as a significant growth-inducing factor for the market. In addition to this, the aging population, which is more susceptible to cancer, is resulting in higher investment in tumor ablation therapies. Besides this, healthcare systems' focus on reducing surgical complications is creating lucrative opportunities in the market. Also, the emergence of precision medicine is positively impacting the market. The market is further propelled by increased healthcare expenditure, particularly in developed countries. Some of the other factors contributing to the market include the rise of medical tourism, greater accessibility to advanced healthcare facilities, and extensive research and development (R&D) activities.

Tumor Ablation Market Trends/Drivers:

Rise in the patient-centric approaches

The modern healthcare landscape is increasingly focusing on personalized care, with treatments being tailored to meet the unique needs and circumstances of each patient. This shift towards patient-centricity has been a game-changer for the tumor ablation market. By designing therapies that consider various patient factors such as age, medical history, and genetic predispositions, healthcare providers are creating highly targeted and effective treatment plans. This personalized approach is particularly important for cancer patients, who often have unique therapeutic responses due to the heterogeneous nature of tumors. By leveraging data analytics, genomics, and personalized medical histories, healthcare providers are better equipped to select the most appropriate tumor ablation therapy for individual patients. This higher degree of personalization not only improves the efficacy of treatments but also increases patient satisfaction and trust, which in turn encourages more people to opt for tumor ablation therapies.

Increasing integration of digital technologies

The integration of digital technologies such as artificial intelligence (AI), machine learning, and big data analytics into healthcare systems is a driving force behind the expansion of the market. These technologies enable healthcare providers to make more informed decisions based on comprehensive data analysis, including patient histories, real-time monitoring, and predictive modeling. These digital advancements are not just limited to patient diagnosis and treatment plans. They also extend to the operational aspects of healthcare systems, streamlining the administration, reducing overhead costs, and improving the efficiency of delivering care. Digital technologies facilitate the real-time sharing of information across different departments or even different healthcare facilities, making it easier to coordinate patient care and adapt treatments as required. This enhanced operational efficiency not only improves patient outcomes but also makes the adoption of tumor ablation therapies more financially viable for healthcare systems.

Rising partnerships and acquisitions amongst key players

The influx of investment from both public and private sectors plays a critical role in shaping the market. Government grants, subsidies, and public funding serve as foundational support for research and development in the healthcare sector. These funds enable medical researchers to explore innovative techniques and technologies in tumor ablation without the immediate pressure of market viability. On the other side, private investment, often in the form of venture capital, accelerates the commercialization process of these new technologies. The alignment of public and private financial interests can often yield breakthrough innovations, as it brings together academic rigor and market-oriented approaches. For instance, public funding can support the early-stage research needed to develop a novel tumor ablation technique, while private investment can facilitate the clinical trials and marketing required to bring it to market. This dual investment stream not only accelerates the pace of innovation but also creates a more robust and dynamic market landscape, fostering competitiveness and, consequently, driving market growth.

Tumor Ablation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global tumor ablation market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.

Breakup by Technology:

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Others

Radiofrequency (RF) ablation represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes radiofrequency (RF) ablation, microwave ablation, cryoablation and others. According to the report, radiofrequency (RF) ablation represented the largest segment.

The radiofrequency (RF) ablation segment is primarily driven by its high efficacy rates, shorter procedure times, and minimally invasive nature. Technological advancements have made RF ablation more precise and safe, attracting physicians and patients alike. Moreover, the cost-effectiveness compared to traditional surgical methods has further boosted its adoption. Reimbursement policies have also been favorable, encouraging the use of RF ablation for tumor treatments. Overall, these factors contribute to its major share in the global tumor ablation market.

On the other hand, microwave, cryoablation, and other methods are becoming increasingly popular due to advancements in technology. They offer alternatives to RF ablation but tend to be more expensive and less covered by insurance. Their adoption is also limited by the need for specialized training for healthcare providers. Despite these challenges, they hold a minor but growing segment in the market.

Breakup by Mode of Treatment:

Percutaneous Ablation

Laparoscopic Ablation

Surgical Ablation

Surgical ablation accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the mode of treatment. This includes percutaneous ablation, laparoscopic ablation, and surgical ablation. According to the report, surgical ablation represented the largest segment.

Surgical ablation remains a conventional and highly effective approach for treating various types of tumors. It is often recommended for cases where the tumor is large or not amenable to minimally invasive techniques. Given the invasive nature, surgical ablation usually necessitates longer hospital stays and recovery periods, which can be a downside. However, its proven efficacy and completeness in tumor removal secure its significant role in the global market.

On the other hand, percutaneous and laparoscopic methods are minimally invasive and preferred for small to medium-sized tumors. These techniques are cost-effective but require specialized equipment and training. Their minor market share is partly due to limitations in treating complex or larger tumors. Nonetheless, they remain valuable options in the broader scope of ablation methods.

Breakup by Mode of Application:

Liver Cancer

Lung Cancer

Kidney Cancer

Bone Metastasis

Others

Liver cancer represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the mode of application. This includes liver cancer, lung cancer, kidney cancer, bone metastasis and others. According to the report, liver cancer represented the largest segment.

Liver cancer dominates the global tumor ablation market, largely due to the high incidence and mortality rates associated with this disease. The ablation techniques offer a viable treatment option for early-stage liver cancer, where surgical removal may not be feasible. As liver cancer is often diagnosed at an advanced stage, ablation techniques are viewed as essential palliative treatments. High adoption rates and the emphasis on research for liver cancer ablation contribute to its significant market share.

On the other hand, the other segments including lung, kidney, and bone metastasis are gradually gaining traction due to technological improvements. These cancers are typically treated with other therapies, but ablation is becoming a more common secondary or complementary option. Limitations in insurance coverage and less substantial clinical evidence compared to major segments hold back their market share.

Breakup by End-User:

Hospitals

Cancer Specialty Clinics

Others

Hospitals accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, cancer specialty clinics and others. According to the report, hospitals represented the largest segment.

Hospitals constitute a significant share of the market due to their comprehensive healthcare services and accessibility to a wide patient demographic. They have the financial capability to invest in advanced ablation technologies, and their multidisciplinary teams can offer a variety of treatment options. With the increasing incidence of cancer, hospitals continue to adopt tumor ablation techniques, solidifying their role in the global market.

On the other hand, specialized cancer clinics focus exclusively on cancer treatment, making them ideal centers for advanced ablation therapies. These clinics often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care. However, these centers may not be as widespread as hospitals, limiting their accessibility. Their specific focus and expertise, though, contribute to an increasing share in the global market.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest tumor ablation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.

North America holds a dominant position in the global market, driven by a number of factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure. The region also benefits from favorable reimbursement policies, which make various ablation treatments more accessible to patients. Furthermore, the prevalence of cancer is relatively high in North America, leading to greater demand for effective treatment methods such as tumor ablation.

Research and development (R&D) activities in the region are vigorous, further propelling the adoption of new and improved ablation techniques. Pharmaceutical and medical device companies in North America also contribute to market growth by investing in research, thereby enhancing the technology and its applications. The presence of key market players headquartered in the region adds to the competitive advantage. Educational campaigns and patient awareness programs are also more prevalent here, aiding in early diagnosis and treatment.

Competitive Landscape:

Leaders in the global tumor ablation market are dedicating resources to clinical trials and research to improve the efficacy and safety of their solutions. They are also focusing on developing minimally invasive techniques to cater to patient comfort and faster recovery. Telehealth integrations are in progress to facilitate remote consultations, thereby increasing the adoption rate of their products. Regulatory approvals are a key focus, and as such, these entities are navigating complex compliance landscapes both domestically and internationally. To maintain a competitive edge, alliances with healthcare providers and medical institutions, and implementation of robust after-sales support and training programs are being formed. Furthermore, educational programs for healthcare professionals are being launched to foster proper utilization of the technology.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Medtronic Public Limited Company

AngioDynamics Inc.

HealthTronics Inc.

NeuWave Medical, Inc.

INTIO Inc.

Galil Medical Ltd

Boston Scientific Corporation

SonaCare Medical LLC

EDAP TMS S.A.

Erbe Elektromedizin GmbH

IceCure Medical Ltd

MISONIX Inc.

Endocare Inc.

CooperSurgical Inc.

B V M Meditech Pvt

Recent Developments:

In August 2023, Medtronic Public Limited Company received CE (Conformite Europeenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life.

In March 2023, AngioDynamics announced several new partnerships with AddLife in the UK, Ireland & Nordics markets. The new distribution arrangements will see Healthcare 21, part of the AddLife Group, distribute AngioDynamics' oncology and surgical product portfolio in the UK and Ireland, and Mediplast in the Nordics.

In August 2023, Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation (AF). The study is the first randomized clinical trial to directly compare the efficacy and safety of the FARAPULSE PFA System against standard-of-care ablation - either radiofrequency or cryoablation - for the treatment of patients with paroxysmal, or intermittent, AF.

Key Questions Answered in This Report

1. What was the size of the global tumor ablation market in 2023?
2. What is the expected growth rate of the global tumor ablation market during 2024-2032?
3. What has been the impact of COVID-19 on the global tumor ablation market?
4. What are the key factors driving the global tumor ablation market?
5. What is the breakup of the global tumor ablation market based on the technology?
6. What is the breakup of the global tumor ablation market based on the mode of treatment?
7. What is the breakup of the global tumor ablation market based on mode of application?
8. What is the breakup of the global tumor ablation market based on the end-user?
9. What are the key regions in the global tumor ablation market?
10. Who are the key players/companies in the global tumor ablation market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Tumor Ablation Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Technology
5.5 Market Breakup by Mode of Treatment
5.6 Market Breakup by Mode of Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast

6 SWOT Analysis

6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats

7 Value Chain Analysis

8 Porter's Five Forces Analysis

8.1 Overview
8.2 Bargaining Power of Buyers
8.3 Bargaining Power of Suppliers
8.4 Degree of Competition
8.5 Threat of New Entrants
8.6 Threat of Substitutes

9 Market Breakup by Technology

9.1 Radiofrequency (RF) Ablation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Microwave Ablation
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Cryoablation
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Mode of Treatment

10.1 Percutaneous Ablation
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Laparoscopic Ablation
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Surgical Ablation
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Mode of Application

11.1 Liver Cancer
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Lung Cancer
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Kidney Cancer
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
11.4 Bone Metastasis
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
11.5 Others
- 11.5.1 Market Trends
- 11.5.2 Market Forecast

12 Market Breakup by End-User

12.1 Hospitals
- 12.1.1 Market Trends
- 12.1.2 Market Forecast
12.2 Cancer Specialty Clinics
- 12.2.1 Market Trends
- 12.2.2 Market Forecast
12.3 Others
- 12.3.1 Market Trends
- 12.3.2 Market Forecast

13 Market Breakup by Region

13.1 North America
- 13.1.1 Market Trends
- 13.1.2 Market Forecast
13.2 Europe
- 13.2.1 Market Trends
- 13.2.2 Market Forecast
13.3 Asia Pacific
- 13.3.1 Market Trends
- 13.3.2 Market Forecast
13.4 Middle East and Africa
- 13.4.1 Market Trends
- 13.4.2 Market Forecast
13.5 Latin America
- 13.5.1 Market Trends
- 13.5.2 Market Forecast

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Medtronic Public Limited Company
- 15.3.2 AngioDynamics Inc.
- 15.3.3 HealthTronics Inc.
- 15.3.4 NeuWave Medical, Inc.
- 15.3.5 INTIO Inc.
- 15.3.6 Galil Medical Ltd
- 15.3.7 Boston Scientific Corporation
- 15.3.8 SonaCare Medical LLC
- 15.3.9 EDAP TMS S.A.
- 15.3.10 Erbe Elektromedizin GmbH
- 15.3.11 IceCure Medical Ltd
- 15.3.12 MISONIX Inc.
- 15.3.13 Endocare Inc.
- 15.3.14 CooperSurgical Inc.
- 15.3.15 B V M Meditech Pvt

簡介目錄圖表

List of Figures

Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
Figure 2: Global: Tumor Ablation Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2023
Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2023
Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2023
Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2023
Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2023
Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
Figure 11: Global: Tumor Ablation Industry: Porter's Five Forces Analysis
Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: North America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million US$), 2024-2032
Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million US$), 2024-2032
Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Tumor Ablation Market Structure
Table 8: Global: Tumor Ablation Market: Key Players

02-2729-4219

+886-2-2729-4219